Search details
1.
JAK1 promotes HDV replication and is a potential target for antiviral therapy.
J Hepatol
; 80(2): 220-231, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37925078
2.
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.
J Gen Virol
; 105(5)2024 05.
Article
in English
| MEDLINE | ID: mdl-38757942
3.
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy.
Hepatology
; 77(3): 802-815, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-35976053
4.
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure.
Gut
; 72(5): 972-983, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36707234
5.
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.
J Hepatol
; 78(5): 958-970, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36702177
6.
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation.
Hepatology
; 76(5): 1345-1359, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35253915
7.
Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production.
PLoS Pathog
; 16(11): e1008593, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33180834
8.
Hypoxia-Inducible Factor 1 Alpha-Mediated RelB/APOBEC3B Down-regulation Allows Hepatitis B Virus Persistence.
Hepatology
; 74(4): 1766-1781, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33991110
9.
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
J Hepatol
; 72(5): 960-975, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31954207
10.
Erratum to 'JAK1 promotes HDV replication and is a potential target for antiviral therapy' [J Hepatol 80 (2024) 220-231].
J Hepatol
; 80(6): 984-985, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38556411
11.
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection.
J Hepatol
; 71(6): 1086-1098, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31349000
12.
Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.
Hepatology
; 68(5): 1695-1709, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29679386
13.
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
J Hepatol
; 68(5): 922-931, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29247725
14.
Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Antimicrob Agents Chemother
; 62(4)2018 04.
Article
in English
| MEDLINE | ID: mdl-29439958
15.
Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
Hepatology
; 66(1): 252-265, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28318036
16.
Liver macrophages: Friend or foe during hepatitis B infection?
Liver Int
; 38(10): 1718-1729, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29772112
17.
Inhibiting cell-to-cell transmission to reach HDV cure: The importance of IFN-α.
J Hepatol
; 77(4): 903-905, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35952820
18.
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
Gastroenterology
; 150(1): 194-205, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26416327
19.
Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.
J Hepatol
; 64(1 Suppl): S41-S48, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27084036
20.
Silencing of the HBV episome through degradation of HBx protein: Towards functional cure?
J Hepatol
; 74(3): 497-499, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33187693